HSBC HOLDINGS PLC

Position in INSM — INSMED Inc

CIK 873630 LONDON, X0

Position in INSM

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$19,042,883

-$2,410,502 QoQ

Shares Held

116,456

-5.5% QoQ

Ownership

0.054%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $964,220,373 across 121 Biotechnology names. INSM ranks #7 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	655,443	$292,681,510
2	REGN	Regeneron Pharmaceuticals, Inc.	323,338	$249,823,869
3	RPRX	Royalty Pharma plc	1,544,018	$74,066,541
4	INCY	Incyte Corp	582,368	$54,812,474
5	ALNY	Alnylam Pharmaceuticals, Inc.	89,619	$29,652,235
6	MRNA	Moderna, Inc.	490,088	$24,896,468
7	INSM	INSMED Inc This page	116,456	$19,042,883
8	PTCT	Ptc Therapeutics, Inc.	227,059	$15,469,528

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$19,042,883	116,456	-5.5%	Shares	Defined	2026-04-30
2025-12-31	$21,453,385	123,267	+8052.6%	Shares	Sole	2026-03-20
2025-09-30	$217,742	1,512	-88.3%	Shares	Sole	2025-11-13
2025-06-30	$1,303,186	12,949	-39.6%	Shares	Sole	2025-08-13
2025-03-31	$1,634,359	21,423	+1.5%	Shares	Sole	2025-05-14
2024-12-31	$1,457,295	21,108	+62.5%	Shares	Sole	2025-02-14
2024-09-30	$947,978	12,986	-43.9%	Shares	Defined	2024-11-14
2024-06-30	$1,551,117	23,151	+45.6%	Shares	Sole	2024-08-12
2024-03-31	$431,257	15,896	+68.7%	Shares	Sole	2024-05-15
2020-12-31	$313,658	9,422	—	Shares	Defined	2021-02-25
No filing history on record for this holder in this stock.